Journals / Şişli Etfal Hastanesi Tıp Bülteni / 2019 / Cilt: 53 - Sayı: 1

Results of Surgical Treatment of Patients with Malignant Eccrine Poroma

Pages
33–36
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The findings of patient series are very useful to guide physicians in these cases.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Malignant eccrine poroma is a rare cutaneous malignancy.
📊
Key Findings & Data:This study was a review of a series of patients with malignant eccrine poroma who underwent surgical treatment conducted in order to evaluate the management techniques and outcomes of treatment modalities.Methods: All cases of surgically excised malignant eccrine poroma performed in a single clinic between 2012 and 2018 were included in the study.
💡
Conclusion & Impact:The findings of patient series are very useful to guide physicians in these cases.
🔬Design:Review & Systematic Survey
📍Scope:2012 Verileri
⚙️Variables:Domain Parameters

Özet

Objectives: Malignant eccrine poroma is a rare cutaneous malignancy. This study was a review of a series of patients with malignant eccrine poroma who underwent surgical treatment conducted in order to evaluate the management techniques and outcomes of treatment modalities.Methods: All cases of surgically excised malignant eccrine poroma performed in a single clinic between 2012 and 2018 were included in the study. The details of patient age, gender, anatomical location of the tumor, histopathological features, and treatmentmodalities were analyzed.Results: The average tumor size was 2.53 cm (range: 0.3-7 cm). The average tumor thickness was 3.06 mm (range: 2.5-4 mm). Themean clean tumor margin after the first excision was 1.28 mm and the mean tumor margin after the second excision was 8.83 mm.No recurrence or distant metastasis was detected in any of the patients during the follow-up period.Conclusion: Unlike frequent skin cancers, rare skin cancers, like malignant eccrine poroma, don’t have definite treatment algorithms constituted from randomized trials. The findings of patient series are very useful to guide physicians in these cases.

🔖

Cite This Article

YAZAR, S. K., SERİN, M. (2019). Results of Surgical Treatment of Patients with Malignant Eccrine Poroma. Şişli Etfal Hastanesi Tıp Bülteni, Cilt: 53 - Sayı: 1, 33–36. https://ajindex.com/articles/363433

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Pinkus H, Mehregan AH. Epidermotropic Eccrine Carcinoma. A Case Combining Features Of Eccrine Poroma And Paget's Dermatosis. Arch Dermatol 1963;88:597–606
  2. Raheemullah A, Allamaneni S, Weber S, Singh R. Eccrine Porocarcinoma Presenting as a Hand Cyst. J Hand Surg Am 2016;41:e425– e427
  3. Masamatti SS, Narasimha A, Bhat A, Chowdappa V. Eccrine Porocarcinoma of the Scalp: A Rare Case Report with Review of Literature. J Clin Diagn Res 2016;10:ED15–6
  4. Asghar AH, Mahmood H, Faheem M, Rizvi S, Khan KA, Irfan J. Porocarcinoma: a rare sweat gland malignancy. J Coll Physicians Surg Pak 2009;19:389–90
  5. Barzi AS, Ruggeri S, Recchia F, Bertoldi I. Malignant metastatic eccrine poroma. Proposal for a new therapeutic protocol. Dermatol Surg 1997;23:267–72
  6. Mandaliya H, Nordman I. Metastatic Eccrine Porocarcinoma: A Rare Case of Successful Treatment. Case Rep Oncol 2016;9:454–6
  7. Sawaya JL, Khachemoune A. Poroma: a review of eccrine, apocrine, and malignant forms. Int J Dermatol 2014;53:1053–61
  8. Snow SN, Reizner GT. Eccrine porocarcinoma of the face. J Am Acad Dermatol 1992;27:306–11
  9. Marone U, Caracò C, Anniciello AM, Di Monta G, Chiofalo MG, Di Cecilia ML, et al. Metastatic eccrine porocarcinoma: report of a case and review of the literature. World J Surg Oncol 2011;9:32
  10. Robson A, Greene J, Ansari N, Kim B, Seed PT, McKee PH, et al. Eccrine porocarcinoma (malignant eccrine poroma): a clinicopathologic study of 69 cases. m J Surg Pathol 2001;25:710–20
  11. Sahn RE, Lang PG. Sentinel lymph node biopsy for high-risk nonmelanoma skin cancers. Dermatol Surg 2007;33:786–92
  12. Luz Mde A, Ogata DC, Montenegro MF, Biasi LJ, Ribeiro LC. Eccrine porocarcinoma (malignant eccrine poroma): a series of eight challenging cases. Clinics (Sao Paulo) 2010;65:739–42
  13. Shiohara J, Koga H, Uhara H, Takata M, Saida T. Eccrine porocarcinoma: clinical and pathological studies of 12 cases. J Dermatol 2007;34:516–22
  14. Xu YG, Aylward J, Longley BJ, Hinshaw MA, Snow SN. Eccrine Porocarcinoma Treated by Mohs Micrographic Surgery: Over 6-Year Follow-up of 12 Cases and Literature Review. Dermatol Surg 2015;41:685–92
  15. Wittenberg GP, Robertson DB, Solomon AR, Washington CV. Eccrine porocarcinoma treated with Mohs micrographic surgery: A report of five cases. Dermatol Surg 1999;25:911–3
  16. D'Ambrosia RA, Ward H, Parry E. Eccrine porocarcinoma of the eyelid treated with Mohs micrographic surgery. Dermatol Surg 2004;30:570–1.